Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

39
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
39
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

31
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
31
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

21
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
21
Panic Disorder01:27

Panic Disorder

170
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
170
Veins of Head and Neck01:19

Veins of Head and Neck

2.7K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
2.7K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

mRNA profiling of caspase-3 and neurofilament light chain in Lennox-Gastaut Syndrome.

Epilepsy research·2026
Same author

Response to the letter to the editor (JOTNS-D-26-00685 by Mantry et al) longer and larger are better than shorter and smaller.

Journal of the neurological sciences·2026
Same author

Status Epilepticus Management in Resource-Limited Settings: An International Expert Survey.

Neurology. Clinical practice·2026
Same author

Long term safety and efficacy of vigabatrin in Lennox-Gastuat syndrome: a long way to go.

Journal of the neurological sciences·2026
Same author

Short-term vigabatrin is safe and effective in Lennox-Gastaut syndrome.

Journal of the neurological sciences·2026
Same author

Status epilepticus in scrub typhus versus tuberculous meningitis: A comparative study.

Epilepsy research·2026

Related Experiment Video

Updated: Sep 6, 2025

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

24.7K

Does gender difference matter in cerebral venous thrombosis?

Jayantee Kalita1, Usha K Misra2, Varun K Singh3

  • 1Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road Lucknow, Uttar Pradesh 226014, India.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|July 2, 2022
PubMed
Summary

Female specific risk factors (FSRFs) are rare in cerebral venous thrombosis (CVT). This study found no significant gender differences in risk factors, clinical presentation, or outcomes for CVT patients.

Keywords:
GenderOral contraceptiveProthrombotic state, cerebral venous thrombosisPuerperiumRisk factor

More Related Videos

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
10:44

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways

Published on: December 9, 2013

12.1K
Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

18.4K

Related Experiment Videos

Last Updated: Sep 6, 2025

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

24.7K
Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
10:44

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways

Published on: December 9, 2013

12.1K
Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

18.4K

Area of Science:

  • Neurology
  • Thrombosis Research
  • Medical Imaging

Background:

  • Cerebral venous thrombosis (CVT) can be influenced by female-specific risk factors (FSRFs).
  • Understanding differences in clinical presentation, imaging, and outcomes between genders and risk factor groups is crucial for CVT management.

Purpose of the Study:

  • To compare clinical, MRI, and outcome parameters in male and female CVT patients.
  • To analyze female CVT patients with and without FSRFs.

Main Methods:

  • A prospective registry of 172 CVT patients was analyzed.
  • Diagnosis was confirmed using magnetic resonance venography (MRV).
  • Risk factors were categorized, and outcomes were assessed using the modified Rankin Scale (mRS) at 6 months.

Main Results:

  • 80 females (46.5%) were included; 24 (30%) had FSRFs, with most also having other risk factors.
  • Hyperhomocysteinemia was more frequent in males, while altered sensorium was more common in females.
  • Outcomes (death, poor, or good) were similar across genders and between females with/without FSRFs.

Conclusions:

  • Isolated FSRFs are uncommon in CVT.
  • No significant gender-based differences were observed in non-FSRFs, clinico-radiological severity, or patient outcomes.